Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The use of
beta-glucuronidase
(beta-GUS) as a reporter and sensitive detection system for Yarrowia lipolytica was studied. The Escherichia coli gusA gene was expressed under control of the homologous
LEU2
promoter in a transcriptional fusion. An NcoI restriction site was introduced at the translational start-ATG, conserving the most favorable context for initiation of translation. The chimeric
LEU2
'-gusA gene was integrated into the
LEU2
locus by homologous recombination. The beta-GUS assay was very sensitive and highly reproducible, using the cytosolic fraction or a total cell extract as the source of enzyme. In a leucine-free medium, beta-GUS activity was at a high, constant level, independent of growth phase. In transformants grown on complete medium, beta-GUS activity was reduced about three-fold, but doubled during logarithmic growth. No intrinsic beta-GUS activity was detectable in untransformed Y. lipolytica and no effect of beta-GUS expression on growth was observed. beta-GUS-producing Y. lipolytica cells could be directly detected on media plates containing X-gluc (5-bromo-4-chloro-3-indolyl-beta-D-glucuronide).
...
PMID:Functional expression of bacterial beta-glucuronidase and its use as a reporter system in the yeast Yarrowia lipolytica. 844 89